{"nct_id":"NCT00124748","title":"Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)","status":"TERMINATED","status_verified_date":"2012-01","start_date":"2005-06","start_date_type":null,"primary_completion_date":"2010-11","primary_completion_date_type":"ACTUAL","completion_date":"2010-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}